The Effect of Long-Acting Mesalamine on Post-Infective Irritable Bowel Syndrome- A Pilot Study

NCT01412372 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Irritable Bowel Syndrome

Interventions

DRUG: Mesalamine
DRUG: Placebo

Sponsor

University of Utah

Collaborators

[object Object]